2023 The first fluorine-containing drug was approved. 2023.01.27 Eli Lilly's Loxo Oncology annou
Scientists from the University of Illinois at Urbana-Champaign and other institutes found that PAC-1
2022.12.12, the US FDA announced the approval of Mirati Therapeutics' oral KRAS G12C inhibitor a
New drugs for Crohn's disease! Eu approves Skyrizi: The First specific IL-23 inhibitor for Crohn's Disease!
Abbvie announced that the European Commission has approved a new indication for Skyrizi, its novel a
HR+ Innovative treatment for Breast cancer! Astrazeneca's next generation estrogen receptor depressant camizestrant phase 3 clinical efficacy is remarkable!
AstraZeneca (AstraZeneca) recently reported positive, high-level results from its phase II trial of
Beijing, Oct. 9, 2022 -- Bayer announced that the global initiative for state and drug administratio
Haihe Pharmaceuticals' Paclitaxel Oral Solution China Marketing Authorization Application Officially Accepted
On September 13, 2022, Shanghai Haihe Pharmaceutical Research and Development Co., Ltd. and South Ko
Parkinson's disease is notoriously difficult to diagnose because it relies primarily on the onse
Targeting a parasite's DNA could be a more effective way to combat malaria, new research from th